You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 17, 2025

Copper-containing Intrauterine Device Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: Copper-containing Intrauterine Device

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Coopersurgical PARAGARD T 380A copper SYSTEM;INTRAUTERINE 018680-001 Nov 15, 1984 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free ⤷  Get Started Free
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 9,265,652 ⤷  Get Started Free ⤷  Get Started Free
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 10,166,141 ⤷  Get Started Free Y ⤷  Get Started Free
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 9,427,351 ⤷  Get Started Free Y ⤷  Get Started Free
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 9,089,418 ⤷  Get Started Free Y ⤷  Get Started Free
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 11,850,181 ⤷  Get Started Free Y ⤷  Get Started Free
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes 12,138,199 ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Patent Landscape for Copper-Containing Intrauterine Devices (IUDs)

Last updated: August 2, 2025

Introduction

Copper-containing intrauterine devices (IUDs) are among the most widely used reversible contraceptive methods globally. As a form of long-acting reversible contraception (LARC), these devices combine copper's spermicidal properties with a T-shaped plastic frame inserted into the uterus. Their efficacy, safety profile, and cost-effectiveness have sustained a robust market presence, while continuous innovation and competitive patenting influence the industry's future trajectory. This article examines the current market dynamics and patent landscape relevant to copper IUDs, providing insights into industry trends, key patent holders, technological positioning, and strategic considerations for stakeholders.

Market Overview

The global copper IUD market has experienced steady growth driven by rising awareness of contraceptive options, expanding insurance coverage, and growing preference for non-hormonal methods. According to a MarketsandMarkets report, the global IUD market was valued at approximately USD 2.4 billion in 2021, with copper IUDs representing a significant share owing to their widespread popularity in both developed and developing markets [1].

Key Market Drivers

  • Enhanced Awareness and Acceptance: Increasing education about non-hormonal contraception options, especially in nations with restrictions on hormonal methods, fuels copper IUD demand.

  • Cost-Effectiveness: As a one-time insertion with a lifespan of up to 10 years, copper IUDs offer economic advantages, influencing their adoption in resource-constrained settings.

  • Regulatory Approvals and Recommendations: Endorsements by WHO and national health authorities favour long-term use, reinforcing market stability.

Market Challenges

  • Side Effects and Discontinuation Rates: Menstrual irregularities and cramping can lead to early discontinuation, constraining market growth.

  • Competitive Pressure from Hormonal IUDs: The rise of hormonal IUDs with longer durations and fewer side effects presents competitive challenges.

  • Supply Chain and Manufacturing Barriers: Manufacturing complexities imposed by patent protections can influence supply and innovation dynamics.

Patent Landscape Analysis

Patents serve as critical strategic assets for device manufacturers, shaping technological evolution and competitive positioning in the copper IUD territory.

Major Patent Holders

Historically, patents related to copper IUDs were held predominantly by industry pioneers such as Teva Pharmaceuticals and Pregna International. These patents covered:

  • Device design and shape: Innovations aimed at minimizing discomfort and optimizing contraceptive efficacy.
  • Copper coating and release mechanisms: Patents focused on the copper wire configuration and the controlled release of copper ions.
  • Insertion techniques and applicators: Techniques for minimally invasive insertion with reduced patient discomfort.

Prominent patent filings date back to the late 20th century, with many now expiring or reaching legal protections' end, opening opportunities for generics and private label manufacturers.

Patent Expiry and Its Impact

The expiration of foundational patents around 2015-2020 has significantly increased market entry for generic copper IUDs. This shift has led to:

  • Price Competition: Lowering costs for healthcare providers and consumers.
  • Innovation Leapfrogging: New entrants exploiting technology gaps to develop improved designs.

Recent Innovations and Patent Activity

Recent patent filings indicate a trend towards:

  • Enhanced Device Design: Focus on reducing insertion pain, increasing contraceptive longevity, and minimizing side effects.

  • Materials Science Advances: Incorporation of novel copper alloys or coatings to improve corrosion resistance and copper release profiles.

  • Smart IUDs: Prototype patents exploring integration with sensors to monitor device status or user compliance.

Despite these advances, the overall patent activity remains relatively moderate compared to hormone-based or implantable contraceptives.

Legal and Regulatory Considerations

While many patents related to the device structure have expired, certain patents concerning specific manufacturing processes, specific copper alloys, or auxiliary components remain active, creating a complex patent landscape that demands careful clearance and freedom-to-operate analyses.

Market Dynamics Influenced by Patent Trends

The expiration of key patents has democratized market access, enabling generic manufacturers to offer cost-competitive products. This catalyzes widespread adoption, especially in emerging markets like India, Africa, and Southeast Asia.

Conversely, ongoing innovation and patent filings targeting device improvements help incumbents maintain competitive advantages and defend market share. The balance between patent expiration-driven generic proliferation and innovation-driven differentiation shapes current market dynamics.

Furthermore, collaborations between academia, biotech startups, and established medical device companies are emerging, aiming to develop smarter devices with integrated monitoring, potentially entering new patent spaces.

Competitive Strategies and Industry Outlook

Major players are increasingly focusing on:

  • Cost leadership: Expanding footprint in low-income regions with affordable, high-quality copper IUDs.

  • Innovation: Investing in materials and device design improvements to enhance user comfort and efficacy.

  • Regulatory Navigation: Securing approvals in key markets and navigating patent landscapes to prevent infringement and facilitate market entry.

The market's future hinges on leveraging patent expiries, fostering incremental innovations, and tailoring solutions to regional preferences and regulatory environments.

Conclusion

The market for copper-containing IUDs exemplifies a mature industry characterized by historic patent protections gradually giving way to generic proliferation, stimulating price competition and wider access. While patent landscapes have promoted innovation historically, recent patent expiries have shifted industry focus toward cost-effective manufacturing and incremental technological enhancements.

Stakeholders must navigate the evolving patent environment, capitalize on emerging innovation opportunities—particularly around device design, material science, and integration with digital health—and adapt to regional market nuances to sustain competitiveness.


Key Takeaways

  • Patent expirations have democratized market access, leading to cost reductions and increased adoption of copper IUDs worldwide.
  • Innovation focus is shifting toward improving device comfort, longevity, and integrating smart features, protected by newer patents.
  • Emerging markets present significant growth opportunities driven by affordability and expanding contraceptive awareness.
  • Manufacturers should monitor patent changes closely to avoid infringement and capitalize on open innovation spaces.
  • Regulatory mechanisms and intellectual property strategies will shape the competitive landscape over the next decade.

FAQs

1. How do patent expirations influence the availability of copper IUDs?
Patent expirations open the market for generic manufacturers, increasing product availability, reducing prices, and expanding access, especially in emerging markets.

2. Are there ongoing innovations in copper IUD technology?
Yes. Recent patents focus on device design improvements, new copper alloys, and smart monitoring features, aiming to enhance user experience and efficacy.

3. What are the main challenges faced by manufacturers in the copper IUD market?
Challenges include managing patent landscapes to avoid infringement, competition from hormone-based IUDs, addressing side effects leading to discontinuation, and regulatory hurdles across different regions.

4. How significant is regional regulation in shaping the copper IUD market?
Regional regulatory policies impact device approval, manufacturing standards, and market entry strategies, influencing overall market dynamics and innovation investment.

5. What role do patent strategies play in the future development of copper IUDs?
Strategic patent filings can protect technological innovations, deter competitors, and extend market exclusivity, influencing the pace and direction of future advancements.


References

[1] MarketsandMarkets. (2022). Intrauterine Devices (IUDs) Market.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.